UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Index level data represents a snapshot of market values at a given time. This explanation covers how levels are computed and used in analysis.
24,561 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Over the weekend, the odds rate hike passed surged, prompting a dramatic re-pricing of the Federal Reserve path. Here...
Marvell Technology has surged as AI workloads push demand for data-center hardware. This article breaks down the driv...
The 2026 World Cup doubles as a proving ground for AI deployments from Big Tech. From AI-enabled devices to officiati...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A niche corner of the tech market has seen attention turn toward optical component makers. This article explains why ...
AI is changing every industry—and with the right approach, you can uncover millionaire-maker artificial intelligence ...
Snowflake posts strong growth while Palantir falters amid sticky macro. Investors shift toward data platforms as the ...
Marvell Technology shows signs of narrowing Broadcom's AI revenue lead as data-center demand accelerates, sparking re...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Meta Platforms stock surged this week as investors cheered hints of in-house AI chips and bigger cloud capacity. We b...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...